APA (7th ed.) Citation

MR, R., PL, L., JM, V., M, d. M. R., A, A. S., AA, H., . . . RG, C. (2023). Predicted deleterious variants in the human genome relevant to gene therapy with adeno-associated virus vectors. Molecular therapy. Methods & clinical development, 31, 101136. https://doi.org/10.1016/j.omtm.2023.101136

Chicago Style (17th ed.) Citation

MR, Rostami, et al. "Predicted Deleterious Variants in the Human Genome Relevant to Gene Therapy with Adeno-associated Virus Vectors." Molecular Therapy. Methods & Clinical Development 31 (2023): 101136. https://doi.org/10.1016/j.omtm.2023.101136.

MLA (9th ed.) Citation

MR, Rostami, et al. "Predicted Deleterious Variants in the Human Genome Relevant to Gene Therapy with Adeno-associated Virus Vectors." Molecular Therapy. Methods & Clinical Development, vol. 31, 2023, p. 101136, https://doi.org/10.1016/j.omtm.2023.101136.